Drug Patents owned by Inforlife

1. List of Midazolam In 0.9% Sodium Chloride drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10966990 INFORLIFE Midazolam in flexible bags
Jun, 2038

(15 years from now)

Drugs and Companies using MIDAZOLAM ingredient

Market Authorisation Date: 22 March, 2021

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of MIDAZOLAM IN 0.9% SODIUM CHLORIDE before it's patent expiration?
More Information on Dosage

2. List of Norepinephrine Bitartrate In 0.9% Sodium Chloride drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10888534 INFORLIFE Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
Apr, 2039

(16 years from now)

Drugs and Companies using NOREPINEPHRINE BITARTRATE ingredient

Market Authorisation Date: 15 September, 2022

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic